# Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting

> **NCT01568268** · PHASE3 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 384 (actual)

## Conditions studied

- Laparoscopic Gynecologic, Abdominal, Other Surgery
- General Anesthesia

## Interventions

- **DRUG:** Palonosetron
- **DRUG:** placebo control group

## Key facts

- **NCT ID:** NCT01568268
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 384 (ACTUAL)
- **Last updated:** 2013-12-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01568268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01568268, "Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01568268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*